Active and passive smoking in childhood is related to the development of inflammatory bowel disease

Suhal S Mahid1, Kyle S Minor, Arnold J Stromberg

  • 1Price Institute of Surgical Research and Section of Colorectal Surgery, Department of Surgery, University of Louisville School of Medicine, Louisville, Kentucky 40292, USA.

Insights

Childhood exposure to tobacco smoke, both active and passive, increases the risk of developing inflammatory bowel diseases (IBD). This finding is significant in Kentucky, a state with high smoking rates and IBD prevalence.

Area of Science:

  • Environmental Health
  • Gastroenterology
  • Epidemiology

Background:

  • Kentucky has the highest smoking prevalence in the U.S., with smoking often starting in childhood.
  • The state also has a high burden of inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis (UC).

Purpose of the Study:

  • To investigate the association between childhood exposure to active and/or passive tobacco smoke and the likelihood of developing IBD.

Main Methods:

  • A prospective study included 672 participants: 253 with CD, 177 with UC, and 242 controls.
  • Participants completed a modified Behavioral Risk Factor Surveillance Survey including questions on childhood passive smoke exposure.

Main Results:

  • Patients with CD and UC were more likely to start smoking regularly by ages 10 and 15, respectively, compared to controls.
  • Early smoking initiation (by age 10) was linked to an earlier UC diagnosis.
  • CD patients showed higher rates of prenatal smoke exposure (OR, 1.72) and childhood passive smoke exposure (OR, 2.04).

Conclusions:

  • Childhood exposure to passive and active tobacco smoke is a significant factor in the development of IBD.
  • The high incidence of IBD in Kentucky highlights the critical role of environmental factors in disease etiology.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...